Inhibrx Depreciation And Amortization from 2010 to 2025
| INBX Stock | USD 81.57 5.36 7.03% |
Depreciation And Amortization | First Reported 2017-12-31 | Previous Quarter 661 K | Current Value 582 K | Quarterly Volatility 240.6 K |
Check Inhibrx Biosciences, financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Inhibrx Biosciences,'s main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.3 M, Selling General Administrative of 134.3 M or Selling And Marketing Expenses of 202.4 K, as well as many indicators such as Price To Sales Ratio of 1.2 K, Dividend Yield of 0.0522 or PTB Ratio of 1.75. Inhibrx financial statements analysis is a perfect complement when working with Inhibrx Biosciences, Valuation or Volatility modules.
Inhibrx | Depreciation And Amortization | Build AI portfolio with Inhibrx Stock |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Inhibrx Stock Analysis
When running Inhibrx Biosciences,'s price analysis, check to measure Inhibrx Biosciences,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Inhibrx Biosciences, is operating at the current time. Most of Inhibrx Biosciences,'s value examination focuses on studying past and present price action to predict the probability of Inhibrx Biosciences,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Inhibrx Biosciences,'s price. Additionally, you may evaluate how the addition of Inhibrx Biosciences, to your portfolios can decrease your overall portfolio volatility.